Genetic variations and transplant outcomes

Nephron - Clinical Practice

Volumn 118, Issue 1, 2010, Pages

  Krüger, Bernd ^a   Schröppel, Bernd ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Acute rejection; Allograft survival; Cardiovascular mortality; Delayed graft function; Functional genetic variants; Kidney transplantation; Posttransplant metabolic complications

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; C REACTIVE PROTEIN; CALCINEURIN INHIBITOR; CROSS REACTING ANTIBODY; CYCLOSPORIN A; CYTOCHROME P450 3A5; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 18; INTERLEUKIN 6; MULTIDRUG RESISTANCE PROTEIN 1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RANTES; TACROLIMUS; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VITAMIN D RECEPTOR; BLOOD CLOTTING FACTOR 5; CHEMOKINE RECEPTOR CCR5; COMPLEMENT COMPONENT C3; CYCLOSPORIN; GLUTATHIONE TRANSFERASE; HEME OXYGENASE 1; HIGH MOBILITY GROUP B1 PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN 9; PROTHROMBIN; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ANTIBODY BLOOD LEVEL; CLINICAL PROTOCOL; DIABETES MELLITUS; DNA POLYMORPHISM; DRUG BIOAVAILABILITY; GENETIC VARIABILITY; GRAFT RECIPIENT; HLA SYSTEM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; METABOLISM; MORTALITY; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; RECURRENT DISEASE; RENAL GRAFT DYSFUNCTION; REVIEW; CYTOKINE PRODUCTION; DELAYED GRAFT FUNCTION; DRUG METABOLISM; GENE EXPRESSION; GENOTYPE; GRAFT SURVIVAL; IMMUNOLOGICAL PARAMETERS; INFLAMMATION; ISCHEMIA REPERFUSION INJURY; KIDNEY BIOPSY; METABOLIC DISORDER; MOLECULE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; REPERFUSION INJURY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

GENETIC PREDISPOSITION TO DISEASE; GRAFT REJECTION; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; SURVIVAL RATE;

EID: 78649257642     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320904     Document Type: Review

References (36)

1. Yarlagadda SG, Coca SG, Formica RN Jr, Poggio ED, Parikh CR: Association between delayed graft function and allograft and patient survival: a systematic review and metaanalysis. Nephrol Dial Transplant 2009;24:1039-1047.
2. Krüger B, Krick S, Dhillon N, Lerner SM, Ames S, Bromberg JS, Lin M, Walsh L, Vella J, Fischereder M, Krämer BK, Colvin RB, Heeger PS, Murphy BT, Schröppel B: Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A 2009;106:3390-3395.
3. Dhillon N, Walsh L, Krüger B, Ward SC, Godbold J, Radwan M, Lin M, Schiano T, Murphy B, Schröppel B: A single nucleotide polymorphism of Toll-like receptor 4 identifies the risk of developing graft failure after liver transplantation. J Hepatol 2010;53:67-72.
4. Israni AK, Li N, Cizman BB, Snyder J, Abrams J, Joffe M, Rebbeck T, Feldman HI: Association of donor inflammation- and apoptosis-related genotypes and delayed allograft function after kidney transplantation. Am J Kidney Dis 2008;52:331-339.
5. Courtney AE, McNamee PT, Middleton D, Heggarty S, Patterson CC, Maxwell AP: Association of functional heme oxygenase-1 gene promoter polymorphism with renal transplantation outcomes. Am J Transplant 2007;7:908-913.
6. Ozaki KS, Marques GM, Nogueira E, Feitoza RQ, Cenedeze MA, Franco MF, Mazzali M, Soares MP, Pacheco-Silva A, Camara NO: Improved renal function after kidney transplantation is associated with heme oxygenase-1 polymorphism. Clin Transplant 2008;22:609-616.
7. Kolesar L, Novota P, Krasna E, Slavcev A, Viklicky O, Honsova E, Striz I: Polymorphism of interleukin-18 promoter influences the onset of kidney graft function after transplantation. Tissue Antigens 2007;70:363-368.
8. Singh R, Manchanda PK, Kesarwani P, Srivastava A, Mittal RD: Influence of genetic polymorphisms in GSTM1, GSTM3, GSTT1 and GSTP1 on allograft outcome in renal transplant recipients. Clin Transplant 2009;23:490-498.
9. Dutkiewicz G, Domanski L, Binczak-Kuleta A, Pawlik A, Safranow K, Ciechanowicz A, Dziedziejko V, Ciechanowski K: The association between eNOS intron 4 VNTR polymorphism and delayed graft function of kidney allografts. Clin Transplant 2009, Epub ahead of print.
10. Nickerson P: The impact of immune gene polymorphisms in kidney and liver transplantation. Clin Lab Med 2008;28:455-468.
11. Cha RH, Yang SH, Kim HS, Kim SM, Park MH, Ha J, Kim YS: Genetic interactions between the donor and the recipient for susceptibility to acute rejection in kidney transplantation: polymorphisms of CCR5. Nephrol Dial Transplant 2009;24:2919-2925.
12. Hoffmann S, Park J, Jacobson LM, Muehrer RJ, Lorentzen D, Kleiner D, Becker YT, Hullett DA, Mannon R, Kirk AD, Becker BN: Donor genomics influence graft events: The effect of donor polymorphisms on acute rejection and chronic allograft nephropathy. Kidney Int 2004;66:1686-1693.
13. Brabcova I, Petrasek J, Hribova P, Hyklova K, Bartosova K, Lacha J, Viklicky O: Genetic variability of major inflammatory mediators has no impact on the outcome of kidney transplantation. Transplantation 2007;84:1037-1044.
14. Breulmann B, Bantis C, Siekierka M, Blume C, Aker S, Kuhr N, Grabensee B, Ivens K: Influence of cytokine genes polymorphisms on long-term outcome in renal transplantation. Clin Transplant 2007;21:615-621.
15. Kruger B, Walberer A, Farkas S, Tokmak F, Obed A, Schenker P, Henning B, Schlitt HJ, Kramer BK, Banas B: The impact of 'highproducer' interleukin-6 haplotypes on cardiovascular morbidity and mortality in a kidney transplant population. Transplant Proc 2009;41:2539-2543.
16. Krüger B, Böger CA, Obed A, Farkas S, Hoffmann U, Banas B, Fischereder M, Krämer BK: Rantes/CCL5 polymorphisms as a risk factor for recurrent acute rejection. Clin Transplant 2007;21:385-390.
17. Hwang YH, Ro H, Choi I, Kim H, Oh KH, Hwang II, Park MH, Kim S, Yang J, Ahn C: Impact of polymorphisms of TLR4/CD14 and TLR3 on acute rejection in kidney transplantation. Transplantation 2009;88:699-705.
18. Palmer SM, Burch LH, Mir S, Smith SR, Kuo PC, Herczyk WF, Reinsmoen NL, Schwartz DA: Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation. Clin Transplant 2006;20:30-36.
19. Ducloux D, Deschamps M, Yannaraki M, Ferrand C, Bamoulid J, Saas P, Kazory A, Chalopin JM, Tiberghien P: Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Kidney Int 2005;67:2454-2461.
20. Krüger B, Böger CA, Schröppel B, Farkas S, Schnitzbauer AA, Hoffmann U, Obed A, Murphy BT, Banas B, Krämer BK: No effect of C-reactive protein (CRP) haplotypes on CRP levels and post-transplant morbidity and mortality in renal transplantation. Transpl Int 2008;21:452-458.
21. Brown KM, Kondeatis E, Vaughan RW, Kon SP, Farmer CK, Taylor JD, He X, Johnston A, Horsfield C, Janssen BJ, Gros P, Zhou W, Sacks SH, Sheerin NS: Influence of donor C3 allotype on late renal-transplantation outcome. N Engl J Med 2006;354:2014-2023.
22. Varagunam M, Yaqoob MM, Dohler B, Opelz G: C3 polymorphisms and allograft outcome in renal transplantation. N Engl J Med 2009;360:874-880.
23. Dhillon N, Walsh L, Krüger B, Ward SC, Godbold J, Radwan M, Lin M, Schiano T, Murphy B, Schröppel B: Complement component C3 allotypes and outcomes in liver transplantation. Liver Transpl 2010;16:198-203.
24. Günesacar R, Opelz G, Erken E, Pelzl S, Döhler B, Ruhenstroth A, Süsal C: VEGF 936 C/T gene polymorphism in renal transplant recipients: association of the T allele with good graft outcome. Hum Immunol 2007;68:599-602.
25. Turpeinen H, Kyllonen LE, Parkkinen J, Laine J, Salmela KT, Partanen J: Heme oxygenase 1 gene polymorphisms and outcome of renal transplantation. Int J Immunogenet 2007;34:253-257.
26. Fischereder M, Luckow B, Hocher B, Wuthrich RP, Rothenpieler U, Schneeberger H, Panzer U, Stahl RA, Hauser IA, Budde K, Neumayer H, Kramer BK, Land W, Schlondorff D: CC chemokine receptor 5 and renaltransplant survival. Lancet 2001;357:1758-1761.
27. Wramner LG, Norrby J, Hahn-Zoric M, Ahlmen J, Borjesson PA, Carlstrom J, Hytonen AM, Olausson M, Hanson LA, Padyukov L: Impaired kidney graft survival is associated with the TNF-alpha genotype. Transplantation 2004;78:117-121.
28. Fischereder M, Schneeberger H, Lohse P, Kramer BK, Schlondorff D, Land W: Increased rate of renal transplant failure in patients with the G20210A mutation of the prothrombin gene. Am J Kidney Dis 2001;38:1061-1064.
29. Meyer M, Laux G, Scherer S, Tran TH, Opelz G, Mytilineos J: No association of factor V Leiden, prothrombin G20210A, and MTH-FR C677T gene polymorphisms with kidney allograft survival: a multicenter study. Transplantation 2007;83:1055-1058.
30. Bamoulid J, Courivaud C, Deschamps M, Mercier P, Ferrand C, Penfornis A, Tiberghien P, Chalopin JM, Saas P, Ducloux D: IL-6 promoter polymorphism-174 is associated with new-onset diabetes after transplantation. J Am Soc Nephrol 2006;17:2333-2340.
31. Numakura K, Satoh S, Tsuchiya N, Horikawa Y, Inoue T, Kakinuma H, Matsuura S, Saito M, Tada H, Suzuki T, Habuchi T: Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus. Transplantation 2005;80:1419-1424.
32. Coto E, Tavira B: Pharmacogenetics of calcineurin inhibitors in renal transplantation. Transplantation 2009;88:S62-S67.
33. Kuypers DR, de Jonge H, Naesens M, Lerut E, Verbeke K, Vanrenterghem Y: CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients. Clin Pharmacol Ther 2007;82:711-725.
34. Grinyo J, Vanrenterghem Y, Nashan B, Vincenti F, Ekberg H, Lindpaintner K, Rashford M, Nasmyth-Miller C, Voulgari A, Spleiss O, Truman M, Essioux L: Association of four DNA polymorphisms with acute rejection after kidney transplantation. Transpl Int 2008;21:879-891.
35. Naesens M, Lerut E, de Jonge H, Van Damme B, Vanrenterghem Y, Kuypers DR: Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts. J Am Soc Nephrol 2009;20:2468-2480.
36. Freedman BI, Nagaraj SK, Lin JJ, Gautreaux MD, Bowden DW, Iskandar SS, Stratta RJ, Rogers J, Hartmann EL, Farney AC, Reeves-Daniel AM: Potential donor-recipient MYH9 genotype interactions in posttransplant nephrotic syndrome after pediatric kidney transplantation. Am J Transplant 2009;9:2435-2440.